← All trials
NCT06916767
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 15, 2025
- Primary completion
- Dec 31, 2027
- Completion date
- Dec 31, 2027
- First posted
- Apr 8, 2025
- Last posted
- Nov 10, 2025
- Enrollment
- 18
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Case Western Reserve UniversityLead sponsor
- Case Western Reserve UniversityOfficial
- The Leukemia and Lymphoma SocietyCollaborator
- Case Western Reserve UniversitySponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.